Genome Editing
CRISPR/Cas9 Genome Editing
08:51Microinjection for Transgenesis and Genome Editing in Threespine Sticklebacks
09:43Breeding by Design for Functional Rice with Genome Editing Technologies
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
09:51Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 20, 2026
Genome Editing: ZFNs, TALENs, and CRISPR-cas9 System
Published on: April 30, 2023
Brian T Emmer1, David Ginsburg2
1Division of Hospital Medicine, Department of Internal Medicine and Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, USA;
Genome editing technologies offer promise for treating genetic diseases, but challenges remain for clinical application, especially in blood cancers. Further research is needed to overcome technical and conceptual barriers for safe and effective therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: